APPBP2 divergent transcript (APPBP2-DT)

APPBP2 divergent transcript (APPBP2-DT) is an annotated gene locus identified as a divergent transcript at or near the APPBP2 gene. There is little to no information regarding its biological function, molecular mechanism, encoded RNA or protein products, or involvement in human disease. No evidence supports a functional role in cell signaling, disease, or drug interaction. It is not classified as a therapeutic target[4][5]. APPBP2-DT is listed in gene databases such as BioGPS and GeneCards as a distinct transcript, but without any functional annotation, protein product, or disease relevance[4][5]. No literature characterizes APPBP2-DT as a receptor, enzyme, transporter, or any molecular entity with therapeutic relevance. The canonical target APPBP2 (Amyloid Beta Precursor Protein Binding Protein 2) is a protein-coding gene involved in microtubule interactions, protein degradation (via ubiquitin ligase complexes), and has emerging roles in cancer biology[1][2][3], but these properties are unrelated to APPBP2-DT. There are no known drugs, biomarkers, safety concerns, or mechanisms linked to APPBP2-DT. "Divergent transcript" implies a transcript produced from the region oppositely oriented to a main gene (here, APPBP2), and such transcripts are frequently noncoding and lack therapeutic significance. APPBP2-DT should not be confused with the functional APPBP2 gene/protein, which does have biological and (potentially) therapeutic importance[1][2][3]. If you intended to ask about the protein-coding APPBP2, additional, detailed information is available.

Other names

APPBP2-DT